...
首页> 外文期刊>Medicine. >Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.
【24h】

Preventing Staphylococcus aureus bacteremia and sepsis in patients with Staphylococcus aureus colonization of intravascular catheters: a retrospective multicenter study and meta-analysis.

机译:预防金黄色葡萄球菌菌血症和败血症在金黄色葡萄球菌在血管内导管中定植的患者:一项回顾性多中心研究和荟萃分析。

获取原文
获取原文并翻译 | 示例

摘要

Two previous studies in tertiary care hospitals identified Staphylococcus aureus colonization of intravascular (IV) catheters as a strong predictor of subsequent S. aureus bacteremia (SAB), even in the absence of clinical signs of systemic infection. Bacteremia was effectively prevented by timely antibiotic therapy. We conducted this study to corroborate the validity of these findings in non-university hospitals.Using the laboratory information management systems of the clinical microbiology departments in 6 Dutch hospitals, we identified patients who had IV catheters from which S. aureus was cultured between January 1, 2003, and December 31, 2008. Patients with demonstrated SAB between 7 days before catheter removal and 24 hours after catheter removal were excluded. We extracted clinical and demographic patient data from the patients' medical records. The primary risk factor was initiation of anti-staphylococcal antibiotic therapy within 24 hours, and the primary endpoint was SAB >24 hours after IV catheter removal. Subsequently, we performed a systematic review and meta-analysis of all observational studies evaluating the effect of antibiotic therapy for S. aureus IV catheter tip colonization.In the current study, 18 of the 192 included patients developed subsequent SAB, which was associated with not receiving antibiotic therapy within 24 hours (odds ratio [OR], 4.2; 95% confidence interval [CI], 1.1-15.6) and with documented exit-site infection (OR, 3.3; 95% CI, 1.2-9.3). When we combined these results with results of a previous study in a university hospital, a third risk factor was also associated with subsequent SAB, namely corticosteroid therapy (OR, 2.9; 95% CI, 1.3-6.3). We identified 3 other studies, in addition to the present study, in a systematic review. In the meta-analysis of these studies, antibiotic therapy yielded an absolute risk reduction of 13.6% for subsequent SAB. The number needed to treat to prevent 1 episode of SAB was 7.4.We conclude that early initiation of antibiotic therapy for IV catheters colonized with S. aureus prevents subsequent SAB.
机译:先前在三级医院中进行的两项研究表明,即使在没有系统感染的临床症状的情况下,金黄色葡萄球菌在血管内(IV)导管中的定植也是随后金黄色葡萄球菌菌血症(SAB)的有力预测指标。及时的抗生素治疗有效地预防了细菌血症。我们进行了这项研究以证实这些发现在非大学医院中的有效性。使用6家荷兰医院的临床微生物学部门的实验室信息管理系统,我们确定了在1月1日之间培养了静脉输注金黄色葡萄球菌的患者。 ,2003年和2008年12月31日。排除在拔除导管前7天到拔除导管后24小时之间表现出SAB的患者。我们从患者的病历中提取了临床和人口统计的患者数据。主要危险因素是在24小时内开始抗葡萄球菌抗生素治疗,主要终点是拔除静脉导管后24小时内的SAB。随后,我们对所有观察性研究进行了系统的回顾和荟萃分析,评估了抗生素治疗对金黄色葡萄球菌IV导管尖端定植的效果。在目前的研究中,包括192名患者在内的18名患者发生了随后的SAB,这与未进行SAB相关在24小时内接受抗生素治疗(赔率[OR],4.2; 95%置信区间[CI],1.1-15.6),并有记录的出院现场感染(OR,3.3; 95%CI,1.2-9.3)。当我们将这些结果与大学医院以前的研究结果相结合时,第三个危险因素也与随后的SAB相关,即皮质类固醇激素治疗(OR,2.9; 95%CI,1.3-6.3)。在系统评价中,除本研究外,我们还确定了其他3项研究。在这些研究的荟萃分析中,抗生素治疗可使随后的SAB绝对风险降低13.6%。预防1次SAB发作所需的治疗数量为7.4。我们得出结论,早期开始对金黄色葡萄球菌定植的IV导管进行抗生素治疗可防止随后的SAB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号